Clinical trial by University Hospitals Seidman Cancer Center in Cleveland leads to practice-changing precision prostate ...
CLEVELAND — A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman Cancer Center in Cleveland has identified the first validated predictive biomarker to guide hormone therapy decisions in …